Treatment for ADHD Reduces Multiple Risk Behaviors
August 26, 2025
Impulsivity and an increase in risk-taking behaviors are hallmarks ...
Read More
Increased Prescribing of ADHD Medication and Real-World Outcomes Over Time
August 8, 2025
A study recently published investigated whether the real-world bene...
Read More
Stimulant Medication Use and Risk of Psychotic Experiences
June 5, 2025
Recent post marketing surveillance and observational studies have s...
Read More
Comparative Cardiovascular Safety of ADHD Medications
May 29, 2025
Concerns about the cardiovascular safety of medications used for th...
Read More
Label Update for Viloxazine ER: New Pharmacodynamic Data and Breastfeeding Info
January 27, 2025
The FDA has approved an update for the label for viloxazine ER to n...
Read More
Prevalence of ADHD in Adulthood
December 5, 2024
Despite the widespread prevalence of ADHD in adulthood, many patien...
Read More
Adult ADHD and Dementia
November 7, 2024
Every year NEI Fall Congress kicks off with multiple pre-conference...
Read More
October Is ADHD Awareness Month
October 13, 2024
October is ADHD Awareness Month. The goal of ADHD Awareness Month i...
Read More
Disrupted Access to Prescription Stimulant Medications
August 12, 2024
The Centers for Disease Control and Prevention (CDC) recently issue...
Read More
FDA Approves Liquid Non-Stimulant ADHD Medication
May 31, 2024
The US FDA has approved once-daily clonidine hydrochloride extended...
Read More
Stimulants and Sleep Difficulties in Pediatric ADHD
March 28, 2024
A recent comprehensive study delved into the long-term effects of m...
Read More
ADHD Pharmacotherapy and Mortality in Individuals With ADHD
March 18, 2024
A recent study explored whether initiation of ADHD pharmacotherapy ...
Read More